Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01825759
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01825759
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01825759. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
- Condition
- Coronary Heart Disease
- Condition
- Essential Hypertension
- Intervention (Drug)
- danshen dripping pill
- Lead sponsor
- West China Hospital
Record details
- Record id
cardio:ct-nct01825759- Content hash
7f455543ef40a0074a6e08593298c55663f10002481be6290f3228619aad7efd